Investigational Site Number 156070

Fuzhou 350005

0 studies enrolling now · 1 studies all time

What they study most

Atherosclerotic Cardiovascular Disease

Studies at this site

• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed